Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsRobert E. Coleman, Nigel Bundred, N. Davidson et al.|Annals of Oncology|2012Cited by 337
Novel Cell Culture Technique for Primary Ductal Carcinoma In Situ: Role of Notch and Epidermal Growth Factor Receptor Signaling PathwaysGillian Farnie, Nigel Bundred|JNCI Journal of the National Cancer Institute|2007Cited by 311
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyHolger Eidtmann, Robert E. Coleman, Richard de Boer et al.|Annals of Oncology|2010Cited by 280
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situG.P. Boland, Nigel Bundred|British Journal of Cancer|2004Cited by 198